Evidence map›Paper›PMID 34297037›Full record

ArticleThe Journal of experimental medicine2021

Epigenetic and transcriptional control of interferon-β.

Andrew W Daman, Steven Z Josefowicz

Open access · greenAbstract read
In one paragraph

Article in The Journal of experimental medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. hESC-Derived Epicardial Cells Promote Repair of Infarcted Hearts in Mouse and Swine.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2023
    Article
  16. Article
  17. Article
  18. Interferon-β Activity Is Affected by S100B Protein.International journal of molecular sciences · 2022
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Andrew W DamanDepartment of Pathology, Weill Cornell Medicine, New York, NY.ORCID 0000-0001-8144-0574
Steven Z JosefowiczDepartment of Pathology, Weill Cornell Medicine, New York, NY.ORCID 0000-0001-7453-779X
Cornell University · US

Funding

Histone Variant H3.3 as a Transcription Rheostat in the Immune SystemR01AI148416 · NIAID · WEILL MEDICAL COLL OF CORNELL UNIV · PI Steven Zvi Josefowicz · 2020 to 2026
$4.6M
Immunology and Microbial Pathogenesis Research Training ProgramT32AI134632 · NIAID · WEILL MEDICAL COLL OF CORNELL UNIV · PI EHRT, SABINE, LI, MING · 2019 to 2023
$747k
Describing the Epigenetic Mechanisms in Control of Hematopoietic Development and Rapid Inflammatory ResponsesF31HL152706 · NHLBI · WEILL MEDICAL COLL OF CORNELL UNIV · PI DAMAN, ANDREW · 2021 to 2023
$140k
NHLBI NIH HHS F31 HL152706NIAID NIH HHS R01 AI148416NIAID NIH HHS T32 AI134632NIH HHS R01AI148416-S1NIH HHS T32 AI134632STARR Cancer Consortium I14-0020
6 · The paper itself

Abstract

The three classes of interferons (IFNs) share the ability to inhibit viral replication, activating cell transcriptional programs that regulate both innate and adaptive responses to viral and intracellular bacterial challenge. Due to their unique potency in regulating viral replication, and their association with numerous autoimmune diseases, the tightly orchestrated transcriptional regulation of IFNs has long been a subject of intense investigation. The protective role of early robust IFN responses in the context of infection with SARS-CoV-2 has further underscored the relevance of these pathways. In this viewpoint, rather than focusing on the downstream effects of IFN signaling (which have been extensively reviewed elsewhere), we will summarize the historical and current understanding of the stepwise assembly and function of factors that regulate IFNβ enhancer activity (the "enhanceosome") and highlight opportunities for deeper understanding of the transcriptional control of the ifnb gene.

Indexed as

Epigenesis, GeneticGene Expression RegulationCCAAT-Enhancer-Binding ProteinsDNA MethylationEnhancer Elements, GeneticHost-Pathogen InteractionsHumansInfluenza A Virus, H5N1 SubtypeInterferon-betaPromoter Regions, GeneticSARS-CoV-2Transcription, GeneticUbiquitin-Protein LigasesCCAAT-Enhancer-Binding ProteinsInterferon-betaUbiquitin-Protein LigasesUHRF1 protein, human

Identifiers

PMID34297037
PMCPMC8313408
OpenAlexW3183468926

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.